Format

Send to:

Choose Destination
See comment in PubMed Commons below
Dement Geriatr Cogn Disord. 2012;34(2):96-111. Epub 2012 Aug 28.

Neuropsychiatric symptoms and global functional impairment along the Alzheimer's continuum.

Author information

  • 1Center for Alzheimer Research and Treatment, Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.

Abstract

BACKGROUND/AIMS:

Neuropsychiatric symptoms in Alzheimer's disease (AD) are highly prevalent. We sought to determine whether neuropsychiatric symptoms were related to global functional impairment at baseline and over a 3-year period in older normal control (NC), mild cognitive impairment (MCI) and mild AD dementia subjects.

METHODS:

Eight hundred and twelve subjects (229 NC, 395 MCI, 188 AD) from the Alzheimer's Disease Neuroimaging Initiative study underwent cognitive and behavioral assessments over 3 years.

RESULTS:

Greater hallucinations, anxiety and apathy were associated with greater global functional impairment at baseline, while the presence of hallucinations and apathy at baseline was associated with greater global functional impairment over time across all subjects. The following neuropsychiatric symptoms were not significantly associated with global functioning: delusions, agitation, depression, euphoria, disinhibition, irritability, aberrant motor behaviors, sleep and appetite.

CONCLUSIONS:

These results suggest that increased baseline hallucinations, apathy and anxiety are associated with current and future disease progression in AD.

Copyright © 2012 S. Karger AG, Basel.

PMID:
22922821
[PubMed - indexed for MEDLINE]
PMCID:
PMC3549662
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for S. Karger AG, Basel, Switzerland Icon for PubMed Central
    Loading ...
    Write to the Help Desk